References
- Leodolter A, Kulig M, Brasch H, Meyer-Sabellek W, Willich SN, Malfertheiner P. A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer. Aliment Pharmacol Ther 2001;15:1949-1958. https://doi.org/10.1046/j.1365-2036.2001.01109.x
- Choi IJ, Kook MC, Kim YI, et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med 2018;378:1085-1095. https://doi.org/10.1056/NEJMoa1708423
- Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 1999;284:1328-1333. https://doi.org/10.1126/ science.284.5418.1328
- Suzuki H, Franceschi F, Nishizawa T, Gasbarrini A. Extra-gastric manifestations of Helicobacter pylori infection. Helicobacter 2011;16 Suppl 1:65-69. https://doi.org/10.1111/j.1523-5378.2011.00883.x
- El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2014;63:871-880. https://doi.org/10.1136/gutjnl-2012-304269
- Kim JH, Kim HY, Kim NY, et al. Seroepidemiological study of Helicobacter pylori infection in asymptomatic people in South Korea. J Gastroenterol Hepatol 2001;16:969-975. https://doi.org/10.1046/j.1440-1746.2001.02568.x
- Lim SH, Kwon JW, Kim N, et al. Prevalence and risk factors of Helicobacter pylori infection in Korea: nationwide multicenter study over 13 years. BMC Gastroenterol 2013;13:104. https://doi.org/10.1186/1471-230X-13-104
- Wu JC, Sung JJ, Chan FK, et al. Helicobacter pylori infection is associated with milder gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2000;14:427-432. https://doi.org/10.1046/j.1365-2036.2000.00714.x
- Koike T, Ohara S, Sekine H, et al. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut 2001;49:330-334. https://doi.org/10.1136/gut.49.3.330
- O'Connor HJ. Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and management. Aliment Pharmacol Ther 1999;13:117-127. https://doi.org/10.1046/j.1365-2036.1999.00460.x
- Zhao Y, Li Y, Hu J, et al. The effect of Helicobacter pylori eradication in patients with gastroesophageal reflux disease: a meta-analysis of randomized controlled studies. Dig Dis 2020;38:261-268. https://doi.org/10.1159/000504086
- Chung SJ, Lim SH, Choi J, et al. Helicobacter pylori serology inversely correlated with the risk and severity of reflux esophagitis in Helicobacter pylori endemic area: a matched case-control study of 5,616 health check-up Koreans. J Neurogastroenterol Motil 2011;17:267-273. https://doi.org/10.5056/jnm.2011.17.3.267
- Ko SH, Baeg MK, Jung HS, Kim P, Choi MG. Russian Caucasians have a higher risk of erosive reflux disease compared with East Asians: a direct endoscopic comparison. Neurogastroenterol Motil 2017;29:e13002. https://doi.org/10.1111/nmo.13002
- Wong BC, Lam SK, Wong WM, et al.; China Gastric Cancer Study Group. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004;291:187-194. https://doi.org/10.1001/jama.291.2.187
- Du YL, Duan RQ, Duan LP. Helicobacter pylori infection is associated with reduced risk of Barrett's esophagus: a meta-analysis and systematic review. BMC Gastroenterol 2021;21:459. https://doi.org/10.1186/s12876-021-02036-5
- Nie S, Chen T, Yang X, Huai P, Lu M. Association of Helicobacter pylori infection with esophageal adenocarcinoma and squamous cell carcinoma: a meta-analysis. Dis Esophagus 2014;27:645-653. https://doi.org/10.1111/dote.12194
- Doorakkers E, Lagergren J, Santoni G, Engstrand L, Brusselaers N. Helicobacter pylori eradication treatment and the risk of Barrett's esophagus and esophageal adenocarcinoma. Helicobacter 2020;25:e12688. https://doi.org/10.1111/hel.12688
- Feldman M, Cryer B, Sammer D, Lee E, Spechler SJ. Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux. Am J Physiol 1999;277:G1159-G1164. https://doi.org/10.1152/ajpgi.1999.277.6.G1159
- Yalaki S, Pulat H, Ilhan A. Localization of Helicobacter pylori gastritis and the relation of existing histopathological features with reflux esophagitis. Scand J Gastroenterol 2020;55:27-33. https://doi.org/10.1080/00365521.2019.1701071
- Kuo YT, Liou JM, El-Omar EM, et al. Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2017;2:707-715. https://doi.org/10.1016/S2468-1253(17)30219-4
- Gobert AP, McGee DJ, Akhtar M, et al. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc Natl Acad Sci U S A 2001;98:13844-13849. https://doi.org/10.1073/pnas.241443798
- Kim SG, Jung HK, Lee HL, et al. Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition. J Gastroenterol Hepatol 2014;29:1371-1386. https://doi.org/10.1111/jgh.12607
- Iijima K, Ohara S, Sekine H, et al. Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut 2000;46:20-26. https://doi.org/10.1136/gut.46.1.20
- Moayyedi P, Bardhan C, Young L, Dixon MF, Brown L, Axon AT. Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology 2001;121:1120-1126. https://doi.org/10.1053/gast.2001.29332
- Nam SY. Helicobacter pylori has an inverse relationship with severity of reflux esophagitis. J Neurogastroenterol Motil 2011;17:209-210. https://doi.org/10.5056/jnm.2011.17.3.209
- Kim N, Lee SW, Kim JI, et al. Effect of Helicobacter pylori eradication on the development of reflux esophagitis and gastroesophageal reflux symptoms: a nationwide multi-center prospective study. Gut Liver 2011;5:437-446. https://doi.org/10.5009/gnl.2011.5.4.437
- Kim BC, Yoon YH, Jyung HS, et al. Clinical characteristics of gastroesophageal reflux diseases and association with Helicobacter pylori infection. Korean J Gastroenterol 2006;47:363-369.
- Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997;112:1442-1447. https://doi.org/10.1016/s0016-5085(97)70024-6
- Schwizer W, Thumshirn M, Dent J, et al. Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial. Lancet 2001;357:1738-1742. Erratum in: Lancet 2001;358:1734. https://doi.org/10.1016/S0140-6736(00)04894-7
- Laine L, Sugg J. Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies. Am J Gastroenterol 2002;97:2992-2997. https://doi.org/10.1111/j.1572-0241.2002.07116.x
- Nam SY, Choi IJ, Ryu KH, Kim BC, Kim CG, Nam BH. Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms. Am J Gastroenterol 2010;105:2153-2162. https://doi.org/10.1038/ajg.2010.251
- Hamada H, Haruma K, Mihara M, et al. High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis. Aliment Pharmacol Ther 2000;14:729-735. https://doi.org/10.1046/j.1365-2036.2000.00758.x
- Sugimoto M, Murata M, Iwata E, Nagata N, Itoi T, Kawai T. Risk of reflux-related symptoms and reflux esophagitis after Helicobacter pylori eradication treatment in the Japanese population. J Clin Med 2021;10:1434. https://doi.org/10.3390/jcm10071434
- Katsurahara M, Imoto I, Umeda Y, et al. Increased reflux esophagitis after Helicobacter pylori eradication therapy in cases undergoing endoscopic submucosal dissection for early gastric cancer. Cancers (Basel) 2021;13:1779. https://doi.org/10.3390/cancers13081779
- Shinozaki S, Osawa H, Hayashi Y, et al. Predictors and timing for the development of symptomatic gastroesophageal reflux disease after successful Helicobactor pylori eradication therapy. Scand J Gastroenterol 2022;57:16-21. https://doi.org/10.1080/00365521.2021.1975310
- Tan J, Wang Y, Sun X, Cui W, Ge J, Lin L. The effect of Helicobacter pylori eradication therapy on the development of gastroesophageal reflux disease. Am J Med Sci 2015;349:364-371. https://doi.org/10.1097/MAJ.0000000000000429
- Qian B, Ma S, Shang L, Qian J, Zhang G. Effects of Helicobacter pylori eradication on gastroesophageal reflux disease. Helicobacter 2011;16:255-265. https://doi.org/10.1111/j.1523-5378.2011.00846.x
- Xie T, Cui X, Zheng H, Chen D, He L, Jiang B. Meta-analysis: eradication of Helicobacter pylori infection is associated with the development of endoscopic gastroesophageal reflux disease. Eur J Gastroenterol Hepatol 2013;25:1195-1205. https://doi.org/10.1097/MEG.0b013e328363e2c7
- Xue Y, Zhou LY, Lin SR, et al. Effect of Helicobacter pylori eradication on reflux esophagitis therapy: a multi-center randomized control study. Chin Med J (Engl) 2015;128:995-999. https://doi.org/10.4103/0366-6999.155049
- Malfertheiner P, Megraud F, Rokkas T, et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut 2022;71:327745. https://doi.org/10.1136/gutjnl-2022-327745
- El-Serag HB, Kao JY, Kanwal F, et al. Houston consensus conference on testing for Helicobacter pylori infection in the United States. Clin Gastroenterol Hepatol 2018;16:992-1002.e6. Erratum in: Clin Gastroenterol Hepatol 2019;17:801. https://doi.org/10.1016/j.cgh.2018.03.013